Revisión Sistemática: Suplementación con L-Arginina para la Prevención de la Restricción del Crecimiento Intrauterino
Why this work is in the frame
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Bibliographic record
Abstract
This systematic review evaluated the effectiveness of L-arginine supplementation for the prevention and treatment of intrauterine growth restriction (IUGR) through evidence synthesis from clinical trials and observational studies. Concurrently, a systematic review was conducted following PRISMA 2020 guidelines. Systematic searches were performed in PubMed, Cochrane Library, Scopus, Web of Science, and LILACS up to October 2024, including randomized controlled trials and observational studies assessing L-arginine supplementation in pregnant women at risk of or diagnosed with IUGR. Methodological quality was assessed using the Jadad scale for clinical trials and the Newcastle-Ottawa scale for observational studies. Data were extracted on population characteristics, interventions, perinatal outcomes, and adverse events. A total of 427 records were identified through systematic search, with 15 studies ultimately included (11 randomized controlled trials and 4 observational studies) involving 1,842 participants. L-arginine supplementation showed a significant increase in birth weight, with a mean difference of 180 grams in high-quality studies. Doses ranged from 3 to 15 grams per day, with 3–6 grams being the most common. Improvements were observed in uteroplacental vascular resistance Doppler parameters and reductions in the incidence of neonatal respiratory distress syndrome. Reported adverse effects were minimal, mainly transient gastrointestinal discomfort. Heterogeneity among studies was moderate, related to differences in diagnostic criteria, dosages used, and timing of intervention onset. Overall, the available evidence suggests that L-arginine supplementation is a potentially beneficial intervention to improve neonatal outcomes in cases of intrauterine growth restriction, with a favorable safety profile. However, significant methodological limitations persist in existing studies, warranting further research through large-scale multicenter clinical trials to establish standardized dosage protocols, optimal initiation timing, and specific populations that may benefit most from this nutritional intervention.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.008 | 0.006 |
| Meta-epidemiology (narrow) | 0.003 | 0.003 |
| Meta-epidemiology (broad) | 0.004 | 0.002 |
| Bibliometrics | 0.002 | 0.006 |
| Science and technology studies | 0.002 | 0.004 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.004 | 0.003 |
| Research integrity | 0.002 | 0.004 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it